Capital Flow Monitor · Sponsors · CIK 1759425
Mirum Pharmaceuticals, Inc.
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404 · 650-667-4085
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$68.5M
Sold
$68.5M
% sold
100.0%
Investors
2
Min investment
$0
Exemption
506(c)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-29 | D ·current | 506(c) | $68.5M | $68.5M | 100.0% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Christopher Peetz — Executive Officer / Director, Foster City, CA
- Eric Bjerkholt — Executive Officer, Foster City, CA
- Peter Radovich — Executive Officer, Foster City, CA
- Laura Brege — Director, Foster City, CA
-
Timothy Walbert — Director, Foster City, CA
1 other raise
- Odyssey Therapeutics, Inc. $214.0M of $214.0M · 100.0%
- William C. Fairey — Director, Foster City, CA
- Patrick Heron — Director, Foster City, CA
- Lon Cardon — Director, Foster City, CA
-
Saira Ramasastry — Director, Foster City, CA
1 other raise
- Kriya Therapeutics, Inc. $320.8M of $320.8M · 100.0%
-
Laurent Fischer — Director, Foster City, CA
1 other raise
- Lycia Therapeutics, Inc. $75.0M of $75.0M · 100.0%
-
Michael Grey — Director, Foster City, CA
2 other raises
- SPRUCE BIOSCIENCES, INC. $50.0M of $50.0M · 100.0%
- Plexium, Inc. $60.1M of $60.1M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.